Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine

The leishmaniases are a complex of vector-borne diseases caused by protozoan parasites of the genus Leishmania. LEISHDNAVAX is a multi-antigen, T-cell epitope-enriched DNA vaccine candidate against human leishmaniasis. The vaccine candidate has been proven immunogenic and showed prophylactic efficac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gene Ther
Main Authors: Riede, O, Seifert, K, Oswald, D, Endmann, A, Hock, C, Winkler, A, Salguero, F J, Schroff, M, Croft, S L, Juhls, C
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4530203/
https://ncbi.nlm.nih.gov/pubmed/25871827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2015.35
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados